Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

80.68
Delayed Data
As of May 23
 +3.03 / +3.90%
Today’s Change
55.00
Today|||52-Week Range
133.62
-25.61%
Year-to-Date

Today’s Trading

Previous close77.65
Today’s open77.97
Day’s range77.69 - 82.07
Volume1,682,677
Average volume (3 months)2,056,974
Market cap$14.6B
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+173.33%
Earnings growth (next 5 years)+56.00%
Revenue growth (last year)+47.36%
P/E ratio317.3
Price/Sales26.95
Price/Book84.68

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.94-1.09%
PRGOPerrigo Company PLC-0.28-0.30%
MDVNMedivation Inc+0.19+0.31%
VRXValeant Pharmaceutic...-1.26-4.59%
Data as of 05/23/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts

Partner Offers

Search for Jobs